Cindy Cao PhD

Dr. Cindy Cao is the Head of US Regulatory Affairs, Sandoz Biopharmaceutical, a Novartis Division. She oversees the Sandoz US regulatory affair biopharm department for all US regulatory activities to support the Sandoz Biosimilar development and commercialization. Dr. Cao provides regulatory strategic counsel to the Sandoz Executive Committee of the Commercial Operations, Intellectual Property, General Legal, Clinical Development, Business Development, Technical Operations. With 16 years of pharmaceutical R & D experience, Dr. Cao has played a leadership role in sanofi, Novo Nordisk, BMS and recently Sandoz, a Novartis Division. She accumulated extensive experience with clinical, nonclinical, CMC and device aspects of development projects as well as marketed products.